S.Korea approves Moderna’s COVID-19 vaccine produced by Samsung Biologics – The Peninsula Qatar

S.Korea approves Moderna’s COVID-19 vaccine produced by Samsung Biologics – The Peninsula Qatar

Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

SEOUL: South Korea granted emergency use approval for Moderna's COVID-19 vaccine produced by South Korean drugmaker Samsung BioLogics, the health ministry said on Tuesday.

Moderna has agreed to distribute 2.44 million doses of the shots produced by Samsung to South Korea after Samsung's COVID-19 vaccine facility on Monday obtained Good Manufacturing Practice (GMP) certification from the drug safety ministry.